MENU
CALT
AS OF
Sep 20 closing price
Price
$40.00
Change
-$0.00 (-0.00%)
Capitalization
1.1B
43 days until earnings call
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CALT Stock CALT is expected to report earnings to fall -147% to -16 cents per share on May 07

GET DAILY SIGNALS
A.I.dvisor
at Tickeron.com
05/06/24
Loading...
CALT - Calliditas Therapeutics AB
Calliditas Therapeutics AB Earnings Graph
Q1'24
Est.
$-0.16
Q4'23
Beat
by $0.12
Q3'23
Beat
by $0.10
Q2'23
Missed
by $0.06
Q1'23
Missed
by $0.33
The last earnings report on December 31 showed earnings per share of -7 cents, beating the estimate of -18 cents. P/B Ratio (17.513) is normal, around the industry mean (10.316). P/E Ratio (0.000) is within average values for comparable stocks, (116.129). CALT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.466). CALT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (4.857) is also within normal values, averaging (233.056). With 5.56K shares outstanding, the current market capitalization sits at 526.47M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
View to see Real Time Patterns for CALT (Try 14 days for $1 only)
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for patients with niche indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se